NASDAQ:PRFX

PainReform News Headlines

$1.95

0.00 (0.00%)

(As of 11/26/2021 12:00 AM ET)

Add

Compare

Today's Range: $1.79
▼
$1.96
50-Day Range: $1.91
▼
$3.21
52-Week Range: $1.75
▼
$7.84

Volume: 225,211 shs
Average Volume: 695,148 shs
Market Capitalization: $20.44 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: -0.53

Media Mentions By Week

PainReform Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRFX
News Sentiment
▼
0.14

0.26
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRFX Articles
This Week
▼
10

0
▲
PRFX Articles
Average Week

Get PainReform News Delivered to You Automatically

PainReform (NASDAQ:PRFX) News Headlines Today

Source

Source	Headline
	AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today - Nasdaq nasdaq.com - November 24 at 9:46 AM
	Rivian News: 12 Things for RIVN Stock Investors to Know About a Potential Deal With RV Rental Company Outdoorsy - Nasdaq nasdaq.com - November 24 at 9:46 AM
	Should You Investigate Perion Network Ltd. (NASDAQ:PERI) At US$25.68? - Nasdaq nasdaq.com - November 22 at 7:34 PM
	How Many Professional Holding Corp. (NASDAQ:PFHD) Shares Do Institutions Own? - Nasdaq nasdaq.com - November 22 at 7:34 PM
	Rivian News: 12 Things for RIVN Stock Investors to Know About a Potential Deal With RV Rental Company Outdoorsy - Investorplace.com investorplace.com - November 22 at 2:34 PM
	These 4 Measures Indicate That PDC Energy (NASDAQ:PDCE) Is Using Debt Extensively - Nasdaq nasdaq.com - November 22 at 2:34 PM
	PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today - InvestorPlace investorplace.com - November 22 at 2:34 PM
	PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today investorplace.com - November 22 at 1:02 PM
	Will PainReform (NASDAQ:PRFX) Spend Its Cash Wisely? finance.yahoo.com - November 22 at 9:33 AM
	Short Interest in PainReform Ltd. (NASDAQ:PRFX) Drops By 31.7% americanbankingnews.com - November 19 at 6:22 PM

	PainReform (NASDAQ:PRFX) Releases Quarterly Earnings Results, Beats Estimates By $0.25 EPS americanbankingnews.com - November 17 at 5:00 PM
	PainReform Provides Business Update for the Third Quarter of 2021 - Yahoo Finance finance.yahoo.com - November 16 at 10:28 PM
	PainReform Provides Business Update for the Third Quarter of 2021 - GlobeNewswire globenewswire.com - November 16 at 12:28 PM
	PainReform Provides Business Update for the Third Quarter of 2021 finance.yahoo.com - November 16 at 12:28 PM
	PainReform to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021 finance.yahoo.com - October 14 at 10:20 AM
	PainReform Provides Business Update for the Second Quarter of 2021 finance.yahoo.com - August 16 at 5:48 PM
	PainReform Up 30% on Heavy Volume marketwatch.com - July 22 at 6:57 PM
	Is PainReform Ltd. (PRFX) A Good Stock To Buy Now? finance.yahoo.com - June 15 at 5:44 PM
	We're Not Very Worried About PainReform's (NASDAQ:PRFX) Cash Burn Rate finance.yahoo.com - May 24 at 2:37 PM
	PainReform Provides Business Update for the First Quarter of 2021 finance.yahoo.com - May 13 at 11:36 AM
	PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief finance.yahoo.com - March 18 at 9:40 AM
	PainReform to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference finance.yahoo.com - March 11 at 12:57 PM
	PainReform Announces $6.0 Million Private Placement finance.yahoo.com - March 8 at 12:50 PM
	PainReform to Present at the H.C. Wainwright BioConnect 2021 Conference feeds.benzinga.com - January 7 at 9:01 AM
	PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations finance.yahoo.com - January 6 at 1:52 PM
	PainReform Ltd.: PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110 finanznachrichten.de - January 4 at 11:47 AM
	PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110 finance.yahoo.com - January 4 at 11:47 AM
	PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer finance.yahoo.com - November 23 at 12:45 PM
	PainReform Welcomes Successful Healthcare and Capital Markets Executive Dr. Ellen Baron to Board of Directors finance.yahoo.com - November 12 at 1:18 PM
	PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors finance.yahoo.com - November 5 at 12:28 PM
	PainReform Ltd.: PainReform Highlights Surgical Advantages of PRF-110 finanznachrichten.de - October 21 at 2:25 PM
	PainReform Commences Preparations for Pivotal Phase 3 Clinical Trials markets.businessinsider.com - October 9 at 7:22 PM
	PainReform Ltd.: PainReform Commences Preparations for Pivotal Phase 3 Clinical Trials finanznachrichten.de - September 29 at 8:35 AM

Get PainReform News Delivered to You Automatically

This page was last updated on 11/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources